Gastrofer 40mg powder and solvent for solution for injection
Dexa Medica
Ingredients in every vial
| Omeprazole | 40 mg |
Each package contains
Other details
| Flavour | None |
W.H.O. classification
| ATC Level 1 | A - Alimentary tract and metabolism |
| ATC Level 2 | A02 - Drugs for Acid Related Disorders |
| ATC Level 3 | A02B - Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord) |
Warnings
Pregnancy
Lactation
Alcohol
Machinery
Available in
 |
Indonesia |
Dosage information
18 YEARS OLD AND ABOVE
1x1 40 mg, intravenously.
Omeprazole intravenous should only be used where oral medication is inappropriate, e.g. in severely ill patients. The dose used in the treatment of Zollinger-Ellison syndrome should be adjusted according to individual response. Dilute with 10 ml WFI, do not used another solvent. Inject over a period of not less than 2.5 minutes. Inject at a rate no greater than 4 ml/min
0 TO 18 YEARS OLD
There is no experience with omeprazole injection in children.
Omeprazole intravenous should only be used where oral medication is inappropriate, e.g. in severely ill patients. The dose used in the treatment of Zollinger-Ellison syndrome should be adjusted according to individual response. Dilute with 10 ml WFI, do not used another solvent. Inject over a period of not less than 2.5 minutes. Inject at a rate no greater than 4 ml/min
IMPAIRED HEPATIC FUNCTION
No dosage adjustment required.
IMPAIRED RENAL FUNCTION
No dosage adjustment required.
ELDERLY PATIENTS
No dosage adjustment required.
Indication
Alternative therapy for the following conditions which cannot be treated effectively with oral medication: duodenal ulcer, gastric ulcer, reflux esophagitis and Zollinger-Ellison syndrome.